Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04808362 |
|---|---|
| Brief Title: | Phase 1/2 Study to Evaluate Safety, PK and Efficacy of the MYC-Inhibitor OMO-103 in Solid Tumours (MYCure) |
| First Submitted : | March 16, 2021 |
| First Submitted that Met QC Criteria : | March 18, 2021 |
| First Posted : | March 22, 2021 |
| Last Update Submitted that Met QC Criteria : | September 27, 2022 |
| Last Update Posted : | September 28, 2022 |